SEC-sourced researchBeta
ORGO
Organogenesis Holdings Inc.
Company comparison ↗
Data passport
- CIK
- 0001661181
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Feb 26, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 433,140,000.0000 | Feb 26, 2026 |
| December 2024 | 482,043,000.0000 | Feb 26, 2026 |
| December 2025 | 564,169,000.0000 | Feb 26, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 564,169,000.0000 | 37,032,000.0000 | -10,309,000.0000 | 598,730,000.0000 | 164,812,000.0000 | Feb 26, 2026 |
| December 2024 | 482,043,000.0000 | 861,000.0000 | 14,208,000.0000 | 497,886,000.0000 | 112,570,000.0000 | Feb 26, 2026 |
| December 2023 | 433,140,000.0000 | 4,945,000.0000 | 30,917,000.0000 | — | — | Feb 26, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $564.17M | December 2025 | Feb 26, 2026 | 10-K |
| Previous period revenueRevenues | $482.04M | December 2024 | Feb 26, 2026 | 10-K |
| Net incomeNetIncomeLoss | $37.03M | December 2025 | Feb 26, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$10.31M | December 2025 | Feb 26, 2026 | 10-K |
| Total assetsAssets | $598.73M | December 2025 | Feb 26, 2026 | 10-K |
| Total liabilitiesLiabilities | $164.81M | December 2025 | Feb 26, 2026 | 10-K |